P

Pappas Capital

27 employees

Bridging the Early-Stage Funding Gap.

Investor insights

Sectors invested in

Biotechnology21
Health Care13
Medical11
Pharmaceutical10
Therapeutics7
Life Science4
Software3
Primary Mitochondrial Myopathy2
Rare Diseases2
Mitochondrial Diseases2
Clinical Trials2
Medical Device2
conditionally active biologics2
development of novel cancer immunotherapies2
antibody evolution and engineering2
protein evolution and engineering2
stem cells and regenerative medicine1
Agriculture1
AgTech1
Farming1

Funding rounds participated in

$52M sweet spot round size

Most of their 27 investments are in rounds between $24M and $75M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Medical Device
Biotechnology
Pharmaceutical
Delivery
Medical Devices
Biopharmaceuticals

Date founded

1994

Investments made

V

VERALOX Therapeutics raised $24M on June 20, 2023

Investors: Sanofi Ventures, JDRF T1D Fund, Genesys Capital, NYBC Ventures and Pappas Capital

H

Horizon Quantum Computing raised $18M on March 31, 2023

Investors: SGInnovate, Tencent, Expeditions Fund and Pappas Capital

V

VFlowTech raised $10M on February 7, 2023

Investors: Carbon Zero Venture Capital, İnci Holding, Sing Fuels, Wavemaker Partners and Pappas Capital

A

Aktis Oncology raised $84M on August 25, 2022

Investors: Octagon Capital Advisors, NS Investment, TCG X, MPM Capital, Merck Group, Vida Ventures, LLC and Pappas Capital

N

NuProbe, Inc. raised $50M on June 2, 2022

Investors: 博远资本, 上海涌铧投资管理有限公司, Sequoia Capital China and Pappas Capital

U

Undisclosed raised $50M on June 2, 2022

Investors: Sequoia Capital China, 博原资本, 上海涌铧投资管理有限公司 and Pappas Capital

U

Us2.ai raised $15M on April 14, 2022

Investors: EDBI Pte Ltd, HEAL Partners, FJ Labs and Pappas Capital

P

Plexium raised $102M on February 23, 2022

Investors: TCG X, The Column Group, Lux Capital, Surveyor Capital, SoftBank Investment Advisers, M Ventures, Neotribe Ventures, RA Capital Management, L.P. and Pappas Capital

A

Avenge Bio raised $45M on January 5, 2022

Investors: Perceptive Advisors, Longitude Capital and Pappas Capital

B

BioAtla, Inc. raised $75M on September 29, 2021

Investors: Ikarian Capital LLC, Great Point Partners, Monashee Investment Management LLC, Hudson Bay Capital Management LP, Soleus Capital Management, L.P. and Pappas Capital

FAQ